We propose that an explanation for some of the DIO variability in this obesity model is that developmental phases affect the expression and function of important adipose biofunctional markers such as Mest, Sfrp5, Scl25a1, and Scd1 in white fat depots. Here, SFRP5 is linked to obesity disorder.